InSightec Announces a New Series D Funding of $50 Million to Accelerate Market Development of MR-Guided Focused Ultrasound Noninvasive Treatments InSightec, the global leader and pioneer in MR-guided focused ultrasound therapy for the non-invasive treatment of tumors, announced today that it is raising in its current D round of capital investment.
http://ift.tt/1vnSITq
http://ift.tt/1vnSITq
No comments:
Post a Comment